Literature DB >> 9389648

Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.

F Liu1, C Pouponnot, J Massagué.   

Abstract

Upon ligand binding, the receptors of the TGFbeta family phosphorylate Smad proteins, which then move into the nucleus where they activate transcription. To carry out this function, the receptor-activated Smads 1 and 2 require association with the product of deleted in pancreatic carcinoma, locus 4 (DPC4), Smad4. We investigated the step at which Smad4 is required for transcriptional activation. Smad4 is not required for nuclear translocation of Smads 1 or 2, or for association of Smad2 with a DNA binding partner, the winged helix protein FAST-1. Receptor-activated Smad2 takes Smad4 into the nucleus where they form a complex with FAST-1 that requires these three components to activate transcription. Smad4 contributes two functions: Through its amino-terminal domain, Smad4 promotes binding of the Smad2/Smad4/FAST-1 complex to DNA; through its carboxy-terminal domain, Smad4 provides an activation function required for Smad1 or Smad2 to stimulate transcription. The dual function of Smad4 in transcriptional activation underscores its central role in TGFbeta signaling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389648      PMCID: PMC316747          DOI: 10.1101/gad.11.23.3157

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  59 in total

1.  Transforming growth factor beta induces myoblast differentiation in the presence of mitogens.

Authors:  A Zentella; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily.

Authors:  J M Graff; A Bansal; D A Melton
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

3.  Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium.

Authors:  J N Topper; J Cai; Y Qiu; K R Anderson; Y Y Xu; J D Deeds; R Feeley; C J Gimeno; E A Woolf; O Tayber; G G Mays; B A Sampson; F J Schoen; M A Gimbrone; D Falb
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

4.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta.

Authors:  P Rossi; G Karsenty; A B Roberts; N S Roche; M B Sporn; B de Crombrugghe
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

5.  A structural basis for mutational inactivation of the tumour suppressor Smad4.

Authors:  Y Shi; A Hata; R S Lo; J Massagué; N P Pavletich
Journal:  Nature       Date:  1997-07-03       Impact factor: 49.962

6.  Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

Authors:  G Lagna; A Hata; A Hemmati-Brivanlou; J Massagué
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

7.  Characterization of functional domains within Smad4/DPC4.

Authors:  M P de Caestecker; P Hemmati; S Larisch-Bloch; R Ajmera; A B Roberts; R J Lechleider
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

8.  Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers.

Authors:  K Uchida; M Nagatake; H Osada; Y Yatabe; M Kondo; T Mitsudomi; A Masuda; T Takahashi; T Takahashi
Journal:  Cancer Res       Date:  1996-12-15       Impact factor: 12.701

9.  Serine phosphorylation, chromosomal localization, and transforming growth factor-beta signal transduction by human bsp-1.

Authors:  R J Lechleider; M P de Caestecker; A Dehejia; M H Polymeropoulos; A B Roberts
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

10.  Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor.

Authors:  G H Thomsen
Journal:  Development       Date:  1996-08       Impact factor: 6.868

View more
  115 in total

1.  Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif.

Authors:  S Germain; M Howell; G M Esslemont; C S Hill
Journal:  Genes Dev       Date:  2000-02-15       Impact factor: 11.361

Review 2.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

3.  A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.

Authors:  M Kretzschmar; J Doody; I Timokhina; J Massagué
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

4.  A function of CBP as a transcriptional co-activator during Dpp signalling.

Authors:  L Waltzer; M Bienz
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

5.  A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation.

Authors:  Z Xiao; X Liu; Y I Henis; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

6.  Structural basis for the functional difference between Smad2 and Smad3 in FAST-2 (forkhead activin signal transducer-2)-mediated transcription.

Authors:  R P Nagarajan; Y Chen
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

7.  Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.

Authors:  S L Stroschein; S Bonni; J L Wrana; K Luo
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

8.  BF-1 interferes with transforming growth factor beta signaling by associating with Smad partners.

Authors:  C Dou; J Lee; B Liu; F Liu; J Massague; S Xuan; E Lai
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

9.  Smads bind directly to the Jun family of AP-1 transcription factors.

Authors:  N T Liberati; M B Datto; J P Frederick; X Shen; C Wong; E M Rougier-Chapman; X F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

10.  G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation.

Authors:  J L Dai; R K Bansal; S E Kern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.